Analysis of newly launched children’s ready-to-eat cereals from 2010 to 2023 revealed concerning nutritional shifts: notable increases in fat, sodium, and sugar alongside decreases in protein and fiber. Children’s cereals contain high levels of added sugar, with a single serving exceeding 45% of the American Heart Association’s daily recommended limit for children. These trends suggest a potential prioritization of taste over nutritional quality in product development, contributing to childhood obesity and long-term cardiovascular health risks.

This study identified a promising trend of declining sedentary behavior among U.S. adults between 2013 and March 2020, but this decline was hampered in 2021-2023. Sedentary lifestyle was widely exacerbated during the COVID-19 pandemic, and this study highlights the enduring impact that this global pandemic may have on daily living patterns. 

Research teams funded by the National Institutes of Health (NIH) have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord with exceptional accuracy. These delivery systems are a significant step toward future precise gene therapy to the brain that could safely control errant brain activity with high precision. In contrast, current therapies for brain disorders mostly treat only symptoms.

NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced new chair and vice chair appointments to the NRG NCI Community Oncology Research Program (NCORP) Cancer Prevention & Control (CPC) Committee.

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic medicines at a price that saves patients over 60%, and public and private insurers over 90%, demonstrating the potential of the nonprofit health care utility (HCU) model to deliver a scalable solution to generic drug affordability. 

A new study published in the Journal of Addiction Medicine found that CUD diagnoses rose substantially across all age, race/ethnicity, and comorbidity subgroups nationwide from 2000 to 2022. These diagnoses were consistently higher among people living with HIV, compared to people living without HIV, and people over 65 experienced the greatest relative increase.